All Outputs (3)

The Use of Tissue-on-Chip Technology to Focus the Search for Extracellular Vesicle miRNA Biomarkers in Thyroid Disease (2023)
Journal Article
Haigh, T., Beattie, H., Wade, M. A., England, J., Kuvshinov, D., Karsai, L., …Green, V. (2024). The Use of Tissue-on-Chip Technology to Focus the Search for Extracellular Vesicle miRNA Biomarkers in Thyroid Disease. International Journal of Molecular Sciences, 25(1), Article 71. https://doi.org/10.3390/ijms25010071

Small extracellular vesicles (sEVs) contain microRNAs (miRNAs) which have potential to act as disease-specific biomarkers. The current study uses an established method to maintain human thyroid tissue ex vivo on a tissue-on-chip device, allowing the... Read More about The Use of Tissue-on-Chip Technology to Focus the Search for Extracellular Vesicle miRNA Biomarkers in Thyroid Disease.

Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system (2023)
Journal Article
Barry, A., Samuel, S. F., Hosni, I., Moursi, A., Feugere, L., Sennett, C. J., …Beltran-Alvarez, P. (2023). Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system. Lab on a chip, 23(11), 2664-2682. https://doi.org/10.1039/d3lc00204g

Arginine methylation is a post-translational modification that consists of the transfer of one or two methyl (CH3) groups to arginine residues in proteins. Several types of arginine methylation occur, namely monomethylation, symmetric dimethylation a... Read More about Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system.

A robust, flow-based, microfluidic device for siRNA-mediated gene knockdown in glioblastoma spheroids (2023)
Journal Article
Hosni, I., Iles, A., Greenman, J., & Wade, M. A. (2023). A robust, flow-based, microfluidic device for siRNA-mediated gene knockdown in glioblastoma spheroids. Innovation and Emerging Technologies, 10, Article 2340005. https://doi.org/10.1142/s2737599423400054

Glioblastoma (GBM) is a deadly disease with a poor prognosis, there is therefore a crucial need for novel therapeutic targets. Current preclinical models of GBM fail to predict clinical outcomes, thus, new translationally relevant models are urgently... Read More about A robust, flow-based, microfluidic device for siRNA-mediated gene knockdown in glioblastoma spheroids.